CLINICAL_TRIALS
trial_result
· 2012-11-26
Clinical Trial Update: Influence of Pramipexole Extended Release on Medication Adherence in Parkinson´s Disease
Summary
A completed Boehringer Ingelheim trial evaluated whether extended-release pramipexole improves medication adherence in Parkinson's disease.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Parkinson Disease | Status: COMPLETED | Results posted: 2012-11-26